Hyperoside protects against chronic mild stress-induced learning and memory deficits

Area of Science:

• Neuroscience
• Pharmacology
• Natural Products

Background:

• Hyperoside is a plant-derived flavonoid with known analgesic and cardiovascular benefits.
• The impact of hyperoside on stress-induced cognitive deficits and its molecular pathways are not well understood.

Purpose of the Study:

• To investigate the effects of hyperoside on cognitive impairment and depressive behaviors in chronic mild stress (CMS) rats.
• To explore the underlying molecular mechanisms, particularly the role of brain-derived neurotrophic factor (BDNF).

Main Methods:

• Utilized a chronic mild stress (CMS) rat model.
• Assessed learning and memory using the Morris water maze test.
• Evaluated depressive symptoms via the forced swim test (FST) and sucrose preference test.
• Measured hippocampal brain-derived neurotrophic factor (BDNF) expression and plasma corticosterone (CORT) levels.
• Investigated the involvement of the BDNF receptor TrkB using the inhibitor K252a.

Main Results:

• Hyperoside treatment significantly improved learning and memory in CMS rats, evidenced by reduced escape latency and swimming distance.
• Hyperoside reversed depressive symptoms in CMS rats, as shown by improvements in the FST and sucrose preference test.
• Hyperoside increased hippocampal BDNF expression in CMS rats, without affecting plasma CORT levels.
• Inhibition of TrkB by K252a blocked the beneficial effects of hyperoside on cognitive function in CMS rats.

Conclusions:

• Hyperoside effectively reverses cognitive impairment and depressive behaviors induced by chronic mild stress in rats.
• The neuroprotective effects of hyperoside are mediated through the regulation of the BDNF signaling pathway, specifically involving the TrkB receptor.